Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma

CONCLUSION: FGF-19 represents a possible novel non-invasive marker for HCC. It may improve the prognosis of HCC patients due to its utility in several aspects of HCC detection and management.PMID:35582295 | PMC:PMC9055196 | DOI:10.4254/wjh.v14.i3.623

Source: World Journal of Hepatology - May 18, 2022 Category: Gastroenterology Authors: Ghada Abdelrahman Mohamed Ehab Hasan Nashaat Hadeer Mohamed Fawzy Ahmed Mohamed ElGhandour Source Type: research